2Suppliers
9Customers
2Debt Items
20Related Chains

Amneal Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
CHRS Coherus Oncology, Inc. 72% Reciprocal relationship from CHRS graph: plans and pension benefit managers (via a team of National Account Directors), servicing account specific questions regarding the billing, coding and reimburs…
SPRY ARS Pharmaceuticals, Inc. 72% Reciprocal relationship from SPRY graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from SPRY g…

Amneal Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
ALKS Alkermes plc 85% Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS g…
ALKS Alkermes plc 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
APACE-PACKAGING-LLC APACE-PACKAGING-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
AVTAR-INVESTMENTS-LLC AVTAR-INVESTMENTS-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
AZATECH-PHARMA-LLC AZATECH-PHARMA-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
KANAN-LLC KANAN-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
TRACY-PROPERTIES-LLC TRACY-PROPERTIES-LLC 85% pment purchase Property, plant and equipment $ — $ 160 Alkermes Plc Inventory and cost of goods sold $ — $ 92 26 The following table summarizes the amounts due to or from the Company for related part…
CHRS Coherus Oncology, Inc. 72% Reciprocal relationship from CHRS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from CHRS graph: plans and pension benefit managers (via a team of National Account Directors…
SPRY ARS Pharmaceuticals, Inc. 72% Reciprocal relationship from SPRY graph: . We believe that NARCAN’s widespread use clearly demonstrates market uptake in response to the advantages of an intranasal product via proven device over inj…

Amneal Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AMRX-DEBT Debt stack $2.7B 90% Market cache reports total debt of $2.7B.
AMRX-DEBT-7745 Xbrl Convertible 90% xbrl convertible detail from xbrl 2019-12-31.

Amneal Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Amneal Pharmaceuticals, Inc..

Amneal Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
AMRX-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 319 tracked holders.

Amneal Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SPRY ARS Pharmaceuticals, Inc. 100.00 1 ['customer', 'supplier']
CHRS Coherus Oncology, Inc. 100.00 1 ['customer', 'supplier']
TEVJF Teva Pharmaceutical Industries Limited 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 50.00 2
ORANY ORANGE 50.00 2
ATR AptarGroup, Inc. 50.00 2
CAH Cardinal Health, Inc. 50.00 2
DERM Journey Medical Corporation 50.00 2
XYF X Financial 50.00 2
NVSEF Novartis AG 50.00 2
GILD Gilead Sciences, Inc. 50.00 2
MCK McKesson Corporation 50.00 2
FMS Fresenius Medical Care AG 50.00 2
NONOF Novo Nordisk A/S 50.00 2
AQST Aquestive Therapeutics, Inc. 50.00 2
NSRX Nasus Pharma Ltd. 50.00 2
MRK Merck & Co., Inc. 50.00 2
IMMP Immutep Limited 50.00 2
AZN AstraZeneca PLC 50.00 2
ALKS Alkermes plc 45.90 1 ['customer']